Stock Forecast
As of Tue Dec 22 2020 00:00:01 GMT+0000 (Coordinated Universal Time) shares of CATB Catabasis Pharmaceuticals 0.93 percentage change in price since the previous day's close. Around 1180490 of 20084000 changed hand on the market. The Stock opened at 2.1 with high and low of 2.04 and 2.24 respectively. The price/earnings ratio is: - and earning per share is -2.14. The stock quoted a 52 week high and low of 1.25 and 8.59 respectively.
BOSTON (AI Forecast Terminal) Tue, Dec 22, '20 AI Forecast today took the forecast actions: In the context of stock price realization of CATB Catabasis Pharmaceuticals is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for CATB Catabasis Pharmaceuticals as below:
CATB Catabasis Pharmaceuticals Credit Rating Overview
We rerate CATB Catabasis Pharmaceuticals because of management is often unable to convert strategic decisions into constructive action; often fails to achieve its financial/operational goals. We use econometric methods for period (n+30) simulate with Pearson-Anson Oscillators Stepwise Regression. Reference code is: 2140. Beta DRL value REG 21 Rational Demand Factor LD 5113.747799999999. Under times of stress, such actions could include dividend cuts, suspension of share repurchases, or maintenance of minimum cash balances. This is particularly relevant for exceptional and strong assessments, where issuers are required to carry higher levels of excess liquidity even during times of stress. For example, when assessing liquidity, we would generally expect companies to be able to cover the full amount of dividends and share repurchases included in our base-case forecast, while still maintaining excess liquidity and achieving the required A/B and A-B measures under a stress case. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for CATB Catabasis Pharmaceuticals as below:
Frequently Asked Questions
Q: What is CATB Catabasis Pharmaceuticals stock symbol?A: CATB Catabasis Pharmaceuticals stock referred as NASDAQ:CATB
Q: What is CATB Catabasis Pharmaceuticals stock price?
A: On share of CATB Catabasis Pharmaceuticals stock can currently be purchased for approximately 2.18
Q: Do analysts recommend investors buy shares of CATB Catabasis Pharmaceuticals ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for CATB Catabasis Pharmaceuticals at daily forecast section
Q: What is the earning per share of CATB Catabasis Pharmaceuticals ?
A: The earning per share of CATB Catabasis Pharmaceuticals is -2.14
Q: What is the market capitalization of CATB Catabasis Pharmaceuticals ?
A: The market capitalization of CATB Catabasis Pharmaceuticals is 43783121
